Home Infusion Therapy Market Tends To Account for Nearly US$ 301 Billion Opportunity during 2022-2032

Newly-released Home Infusion Therapy industry analysis report by Fact.MR shows that global sales of Home Infusion Therapy in 2021 was held at US$ 31 Bn. With 8.6%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. Infusion Pumps is expected to be the highest revenue-generating product, accounting for an absolute dollar opportunity of nearly US$ 301 Bn during 2022 – 2032.

Download Free Sample Copy Of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7169

What Factors are propelling the growth of Home Infusion Market?

Continuous advancements in home infusion therapy, including the availability of care workers, remote patient management and transparency about the quality of care, has been assisting the industry growth ahead.

Rapid technical improvements in intravenous equipment, as well as favourable government laws for older people, have boosted demand for home infusion therapy devices, which has had a substantial influence on market growth. Furthermore, the rising incidence of chronic diseases including cardiovascular disease, orthopaedic disease, diabetes, and cancer, among others, is expected to boost the market ahead.

Which Region is projected to Offer the Largest Opportunity for Home Infusion Therapy?

North America dominated the market in 2021, with a revenue share of over 40%, and this trend is expected to continue throughout the forecast period. This can be attributed to increasing R&D in the region as well as greater utilisation of new infusion pump technology. Increased demand for long-term therapy for people with certain conditions is driving the regional market. The development of alternative healthcare venues and home infusion services, as well as a movement in preference from acute care to home care settings due to reduced costs and more patient mobility, will propel this industry forward in the future years.The increased need for infusion therapies in the U.S. has resulted in its global dominance in the market. The provision of patient care outside of medical settings has grown considerably in the U.S. The country’s elderly population contributes significantly to this trend. Healthcare organizations in the country are gradually switching the patient care to homecare settings in order to save money and resources. Public health officials in the U.S. have launched a variety of campaigns to promote awareness about homecare. Due to a variety of payment schemes for medical equipment, the home infusion therapy industry in the country has grown in leaps and bounds.The increased acceptance of non-hospital operations, as well as a huge base of geriatric customers who require infusion therapies on a regular basis, are further driving demand for home infusion therapy equipment in the U.S.

Share Your Requirements & Get Customized Reports: https://www.factmr.com/connectus/sample?flag=S&rep_id=7169

Competitive Analysis

CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd. are some of the key players in the global home infusion therapy market. One of the key factors boosting industry rivalry among market rivals is the rapid use of contemporary healthcare technologies for improved healthcare services. To retain market share and broaden their product range, significant players commonly adopt techniques such as mergers, acquisitions, and new product releases.

Some of the recent developments of key Home Infusion Therapy providers are as follows:

• In May 2021, Smiths Medical and Ivenix, Inc. announced a partnership to deliver a comprehensive range of infusion management solutions to the U.S. market. The goal of this partnership is to enhance infusion administration and patient safety.
• In March 2021, PromptCare purchased NBN Infusions, Inc, a home infusion and respiratory treatment service provider located in New Jersey. NBN Infusions, Inc. specialises in providing infusion treatment to critically ill patients. PromptCare will gain market share in the Northeastern United States as a result of this transaction.
• In December 2021, Baxter International announced the purchase of Hillrom. It will help the firm extend its global reach while also integrating medical device innovations to improve patient care, save costs, and streamline operations.
• In February 2020, Avoset created a homecare system, AvosetGO, an infusion pump device with embedded touch displays that can be connected and monitored via smart devices.
• In March 2021 Terumo and Glooko, a company that creates remote patient monitoring software and mobile apps, formed a technical agreement to provide diabetes data solutions throughout the world. As a result of the collaboration, data from Terumo’s diabetes care devices will be linked into Glooko’s diabetic data management platform, Diasend.
• In May 2020, the Australian Therapeutic Goods Administration awarded the Evo IQ Syringe Infusion System CE marking and marketing approval.

Full Access Of This Report Is Available At: https://www.factmr.com/checkout/7169

>Market Segments Covered in Home Infusion Therapy Industry Analysis

• By Product Type :
  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Other Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needless Connectors
• By Application Type :
  • Anti-Infective
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Other Applications
• By Region :
  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Check Out More Related Studies Published By Fact.MR Research: https://www.prnewswire.com/news-releases/medical-suction-devices-market-to-register-4-cagr-as-installation-of-ac-powered-machines-surges-in-emergency-care-settings-301632917.html